Soft tissue sarcomas.
Soft tissue sarcomas in infants and children differ from those in adults in clinical presentation, histology, and response to therapy. For rhabdomyosarcoma, the most common sarcoma in children, each primary site has special characteristics that affect both treatment programs and survival rates. Some results are so good, from the standpoint of survival data, that studies are now in progress to evaluate means of reducing treatment morbidity. Other ongoing studies focus on improved protocols for metastatic or recurrent rhabdomyosarcoma. Results thus far in the IRS trials have proven the value of cooperative clinical trials in the management of patients with this disease.
Lawrence
W
W
Division of Surgical Oncology, Medical College of Virginia, Virginia Commonwealth University, Richmond.
Neifeld
J P
JP
D000293:Adolescent; D002648:Child; D003131:Combined Modality Therapy; D006801:Humans; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D011379:Prognosis; D012208:Rhabdomyosarcoma / Q000473:pathology / Q000628:therapy; D012509:Sarcoma / Q000175:diagnosis / Q000628:therapy*; D012983:Soft Tissue Neoplasms / Q000175:diagnosis / Q000556:secondary / Q000628:therapy*